mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.028 |
0.4 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.4 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.4 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.4 |
mRNA |
nakiterpiosin |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K16147474 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.4 |